A Randomized Crossover Trial of Bright Light Therapy in Irritable Bowel Syndrome
NCT: NCT06676488 · COMPLETED
Brief Summary
The purpose of this research study is to assess whether morning bright light therapy (BLT) using a wearable device called a Re-Timer could potentially improve Irritable Bowel Syndrome (IBS) symptoms and decrease intestinal permeability (leaky gut). Morning bright light therapy will be administrated through a safe-wearable glasses device called a Re-Timer. The Re-Timer glasses are lightweight and deliver blue-green light at 500nm, mimicking exposure to natural light.
Frequently Asked Questions
What is A Randomized Crossover Trial of Bright Light Therapy in Irritable Bowel Syndrome?
A Randomized Crossover Trial of Bright Light Therapy in Irritable Bowel Syndrome is a clinical trial registered under NCT06676488. Current status: COMPLETED.
What is the status of NCT06676488?
The current status of NCT06676488 (A Randomized Crossover Trial of Bright Light Therapy in Irritable Bowel Syndrome) is: COMPLETED.
When did A Randomized Crossover Trial of Bright Light Therapy in Irritable Bowel Syndrome start?
A Randomized Crossover Trial of Bright Light Therapy in Irritable Bowel Syndrome started on 2025-06-11.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.